Accelerate to discover
Related topics
Introducing the first EV isolation column capable of running 100 mL samples.
May 21, 2019
As the EV field continues to grow and advance, so has the need for scalability in EV isolation. Izon is addressing this...
Assessment of myocardial dynamics using photoacoustics & cardiac elastography
May 17, 2019
Are you interested in Principles of Photoacoustic (PA) Imaging, and its application in cardiovascular research? Don’t...
Webinar recording: Detecting cancer-associated structural variants using Bionano optical maps
May 15, 2019
Bionano’s genome mapping technology directly observes long molecules from 150,000 bp to megabase pair lengths to...
PET/CT Si78: Versatility in microCT dose, speed, & resolution
May 9, 2019
The Bruker PET/CT Si78 now pairs total-body PET and SkyScan microCT technology. This combination offers the advanced...
Cell by cell lung cancer marker profiling using high-parameter spectral flow cytometry
May 2, 2019
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for 80-85% cases of lung cancer....
We are pleased to announce the launch of the xxpress NGx
Apr 30, 2019
The new xxpress thermal cycler has an upgraded optics system that provides better channel separation and enhanced...
In Vivo Bioluminescence Imaging of Cobalt Accumulation in a Mouse Model
Apr 26, 2019
As a trace element nutrient, cobalt is critical for both prokaryotes and eukaryotes. In the current study, a turn-on...
Bionano Genomics news presented at AGBT 2019
Apr 23, 2019
2019 is starting off with a bang for Bionano with higher throughput on Saphyr, easier and faster sample prep, detection...
Feb 12, 2018
Current methods for assessing the growth and shrinkage of tumor spheroids are limited by one or more of the following: (1) assay workflows that are time-consuming, expensive or laborious, (2) a requirement to label the cells (e.g. a fluorescent probe) which may perturb the biology and may not be amenable to primary tissue, (3) single time-point readouts that do not report the full timecourse, (4) indirect readouts (e.g. ATP) that may overlook valuable morphological insight and/or mis-report cell growth.In this application note we describe methods and validation data for miniaturized (96/384-well) live-cell tumor spheroid assays that are based on non-invasive bright-field image analysis performed with the IncuCyte S3 Spheroid software module. Tumor spheroids are formed in ultra-low attachment (ULA) plates and monitored for size and morphology for up to 2 weeks. These assays are flexible, simple to run and provide automated and direct measures of tumor size in real-time.
Related technologies: Automated microscopy and image analysis | Time-lapse microscopy
Get more info
Brand profile
Essen BioScience (part of Sartorius), is a team of engineers and biologists with deep expertise in cell-based assays. We invent, manufacture, supply and support cell-based assay instrumentation, reagents and protocols.
More info at:
www.essenbioscience.com/
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
